Skip to main content
Top
Published in:

Open Access 01-12-2024 | Case Report

Acinetobacter ursingii peritonitis in a patient on peritoneal dialysis (PD): case report and literature review

Authors: R. Haridian Sosa Barrios, Reiny S. Verastegui Albites, Mariana López Quiroga, Cristina Campillo Trapero, Milagros Fernández Lucas, Maite E. Rivera Gorrín

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Background

Peritonitis is a frequent complication of PD that can lead to technique discontinuation and increase morbidity and mortality. It is caused mainly by gram-positive bacteria (up to 70%); however, gram-negative organisms usually have relatively poor outcomes. Among gram-negative bacteria, Acinetobacter is rare, especially Acinetobacter ursingii.

Case report

We report the third case of PD peritonitis caused by Acinetobacter ursingii, treated with directed intraperitoneal antibiotics with good clinical response and favorable outcome.

Conclusion

Although Acinetobacter ursingii is rare, it is potentially harmful because of its challenging identification and antibiotic resistance with therapeutic consequences, requiring at least two antibiotics and careful follow up. Keeping in mind that it is ubiquitous, careful technique, training/retraining seems highly recommended.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hansson JH, Watnick S. Update on peritoneal dialysis: core curriculum 2016. Am J Kidney Dis. 2016;67(1):151–64.CrossRefPubMed Hansson JH, Watnick S. Update on peritoneal dialysis: core curriculum 2016. Am J Kidney Dis. 2016;67(1):151–64.CrossRefPubMed
4.
go back to reference Seifert H, Dijkshoorn L, Gerner-Smidt P, et al. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol. 1997;35:2819–25.CrossRefPubMedPubMedCentral Seifert H, Dijkshoorn L, Gerner-Smidt P, et al. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol. 1997;35:2819–25.CrossRefPubMedPubMedCentral
5.
go back to reference Arsanios D et al. Catheter-related bloodstream infection due to Acinetobacter ursingii in a hemodialysis patient: case report and literature review. PanAfrican Medical Journal. 2021; 39(208). Arsanios D et al. Catheter-related bloodstream infection due to Acinetobacter ursingii in a hemodialysis patient: case report and literature review. PanAfrican Medical Journal. 2021; 39(208).
6.
go back to reference Nemec A, et al. Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens. Int J Syst Evol MicroBiol. 2001;51:1891–9.CrossRefPubMed Nemec A, et al. Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens. Int J Syst Evol MicroBiol. 2001;51:1891–9.CrossRefPubMed
7.
go back to reference Chao C-T, et al. Acinetobacter peritoneal dialysis peritonitis: a changing Landscape over Time. PLoSONE. 2014;9(10):e110315.CrossRef Chao C-T, et al. Acinetobacter peritoneal dialysis peritonitis: a changing Landscape over Time. PLoSONE. 2014;9(10):e110315.CrossRef
8.
go back to reference Li PH, Cheng VC, Yip T, Yap DY, Lui SL, Lo WK. Epidemiology and clinical characteristics of Acinetobacter Peritoneal Dialysis-Related Peritonitis in Hong Kong-with a perspective on Multi-drug and Carbapenem Resistance. Perit Dial Int. 2017;37(2):177–82.CrossRefPubMed Li PH, Cheng VC, Yip T, Yap DY, Lui SL, Lo WK. Epidemiology and clinical characteristics of Acinetobacter Peritoneal Dialysis-Related Peritonitis in Hong Kong-with a perspective on Multi-drug and Carbapenem Resistance. Perit Dial Int. 2017;37(2):177–82.CrossRefPubMed
9.
go back to reference Atas DB, Velioglu A, Asicioglu E, Tigen E. Peritoneal dialysis-related peritonitis with Acinetobacter Ursingii. Therapeutic Apheresis Dialysis. 2016;20(2):205–11. Atas DB, Velioglu A, Asicioglu E, Tigen E. Peritoneal dialysis-related peritonitis with Acinetobacter Ursingii. Therapeutic Apheresis Dialysis. 2016;20(2):205–11.
11.
go back to reference Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B. Clinical and pathophysiological overview of Acinetobacter infections: a Century of challenges. Clin Microbiol Rev. 2017;30(1):409–47.CrossRefPubMed Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B. Clinical and pathophysiological overview of Acinetobacter infections: a Century of challenges. Clin Microbiol Rev. 2017;30(1):409–47.CrossRefPubMed
12.
go back to reference Dortet L, Legrand P, Soussy CJ, Cattoir V, Bacterial, Identification. Clinical significance, and Antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens. J Clin Microbiol. 2006;44(12):4471–8.CrossRefPubMedPubMedCentral Dortet L, Legrand P, Soussy CJ, Cattoir V, Bacterial, Identification. Clinical significance, and Antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens. J Clin Microbiol. 2006;44(12):4471–8.CrossRefPubMedPubMedCentral
13.
go back to reference Chiu CH, et al. A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii. BMC Infect Dis. 2015;15:400.CrossRefPubMedPubMedCentral Chiu CH, et al. A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii. BMC Infect Dis. 2015;15:400.CrossRefPubMedPubMedCentral
14.
go back to reference Chow KM, Szeto CC, Law MC, Fun Fung JS, Li KTP. Influence of peritoneal dialysis training nurses’ experience on peritonitis rates. Clin J Am Soc Nephrol. 2007;2:647–52.CrossRefPubMed Chow KM, Szeto CC, Law MC, Fun Fung JS, Li KTP. Influence of peritoneal dialysis training nurses’ experience on peritonitis rates. Clin J Am Soc Nephrol. 2007;2:647–52.CrossRefPubMed
Metadata
Title
Acinetobacter ursingii peritonitis in a patient on peritoneal dialysis (PD): case report and literature review
Authors
R. Haridian Sosa Barrios
Reiny S. Verastegui Albites
Mariana López Quiroga
Cristina Campillo Trapero
Milagros Fernández Lucas
Maite E. Rivera Gorrín
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-024-03881-8

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
 

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Register your interest now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more